PetMed Express Inc.
Last updated September 27, 2026
Organization details
- Legal name
- PetMed Express Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 5912 — Retail-Drug Stores and Proprietary Stores
- Jurisdiction of incorporation
- Florida
- Headquarters city
- Delray Beach
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- March
- Ticker symbol
- PETS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001040130
- EIN
- 65-0680967
- Wikidata ID
- Q7171526
Board of directors
-
Diana G. Purcel · DirectorSince 2023
-
Gian Fulgoni · DirectorSince 2023
-
James LaCamp · DirectorSince 2025
-
Jeffrey Allen Willard · Director · CEO and PresidentSince 2026
-
Justin L. Mennen · DirectorSince 2024
-
Leah Solivan · DirectorSince 2024
-
Leslie C.g. Campbell · Director · Interim CEO and PresidentSince 2023
-
Mathew N. Hulett · Director · CEO & PresidentSince 2023
-
Peter Batushansky · DirectorSince 2025
-
Sandra Yvette Campos · Director · CEO & PresidentSince 2023
-
Tamar Elkeles · DirectorSince 2026
Chief executives
Jeffrey Allen Willard
· CEO and President
Since September 2026
Mathew N. Hulett
· CEO & President
Until September 2026
· Former
Sandra Yvette Campos
· CEO & President
Until September 2026
· Former
Until September 2026
· Former
Director election results
Annual meeting of August 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
67.7%
-
69.1%
-
70.7%
-
72.3%
Board connections
2 of this board's directors also sit on 2 other boards.
- via Tamar Elkeles
- via Diana G. Purcel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $43,750
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 28, 2026 | Jeffrey Allen Willard Director, Officer (CEO and President) | Grant or award | +250,000 | — | — |
| Sep 17, 2026 | Tamar Elkeles Director | Grant or award | +49,923 | — | — |
| Aug 11, 2026 | Peter Batushansky Director | Grant or award | +55,555 | — | — |
| Aug 11, 2026 | James LaCamp Director | Grant or award | +55,555 | — | — |
| Aug 11, 2026 | Justin L. Mennen Director | Grant or award | +55,555 | — | — |
| Aug 11, 2026 | Leslie C.g. Campbell Director, Officer (Interim CEO and President) | Grant or award | +60,000 | — | — |
| Jun 26, 2026 | KRULIK DOUGLAS Officer (CAO and Interim CFO) | Grant or award | +32,500 | — | — |
| Jun 8, 2026 | MATZ ZYMAN STEPHANNIE 10% owner | Open-market purchase | +25,000 | $1.75 | $43,750 |
| Jan 21, 2026 | Gian Fulgoni Director | Sold back to the company | −26,057 | — | — |
| Oct 30, 2025 | Gian Fulgoni Director | Grant or award | +33,846 | — | — |
| Oct 30, 2025 | KRULIK DOUGLAS Officer (CAO and Interim CFO) | Grant or award | +20,000 | — | — |
| Oct 30, 2025 | James LaCamp Director | Grant or award | +34,866 | — | — |
| Oct 30, 2025 | Justin L. Mennen Director | Grant or award | +33,846 | — | — |
| Oct 30, 2025 | Leah Solivan Director | Grant or award | +33,846 | — | — |
| Oct 30, 2025 | Peter Batushansky Director | Grant or award | +33,846 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.